Hepatocellular carcinoma is a tumor with a high incidence and high mortality. These data .. manejo del CHC celebrada en Barcelona en el an˜o definieron por vez primera .. hepática (clasificación Child-Pugh) y presencia de sıntomas. The present manuscript depicts the Barcelona‐Clínic Liver Cancer Group diagnostic and treatment strategy. This is based on the analysis of. The value of the Barcelona Clinic Liver Cancer and alpha-fetoprotein in the Conclusiones: nuestros resultados confirman que la clasificación BCLC es un.

Author: Mazudal Maugis
Country: Angola
Language: English (Spanish)
Genre: History
Published (Last): 22 March 2004
Pages: 238
PDF File Size: 20.35 Mb
ePub File Size: 8.21 Mb
ISBN: 717-5-39766-339-8
Downloads: 32429
Price: Free* [*Free Regsitration Required]
Uploader: Doumuro

Investigators in Hong Kong described a staging system analysing their experience in patients, most xe them with HBV-related cirrhosis Cancer staging should serve to select the appropriate primary and adjuvant therapy, to estimate the prognosis, and also to assist in the evaluation of the results of treatment, and to exchange information without ambiguity Others studies also found a biologic role of AFP 39, In this review, the AFP was among the first five significant variables in 20 studies.

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Eur Radiol ;17 Supl. The figure 3 shows the survival curves according the serum AFP. Conversely they face the same difficulty in early cases, as prognostic modeling for early HCC has specific requirements 2627 High AFP may contribute to the metastatic potential and tumor progression and is an important unfavorable prognostic factor for HCC after tumor resection They hepafocarcinoma rough descriptions of tumor stage that are not in accordance with the predictive value of tumor size and multicentricity.

In brief, patients at stage 0 with very early HCC are optimal candidates for resection. The most frequent cause of liver disease was hepatitis C infection The strategic role of staging in the treatment of HCC.


Survival of early stage patients is modified by treatment and thus, prognostic prediction has to include treatment-related variables. Treatment failure was defined as the persistence of contrast enhancement within the tumoral area after completing treatment. Fagiuoli S, et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Some studies found that HCC patients with high AFP tended to have greater tumor size, bilobar involvement, massive or diffuse types, and portal vein thrombosis, and equally, AFP was a prognostic indicator More than 20 RCTs have been bwrcelona, including an untreated arm of conservative management Very early 11 A: Patients at stage C with advanced HCC may receive new agents in the setting of RCT, and patients at stage D with end-stage disease will receive symptomatic treatment.

Colombo M, Sangiovanni A.

Open in a separate window. Hepatocellular carcinoma HCC is a major health problem worldwide. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection.

These outcomes are the result of applying the so-called treatment-dependent clasoficacion in the selection of candidates. Differentiation of early well-differentiated HCC from preneoplastic lesions is a histopathologic challenge, and molecular markers are awaited in this setting 14 Eur J Cancer ; Initially several therapeutic strategies were used.

Staging systems in hepatocellular carcinoma

Estrogen receptor classification for hepatocellular carcinoma: The aim of this study was to evaluate the BCLC classification in our clinical practice and to know what the prognostic value of AFP is. Acknowledgments The authors wish to thank Rafael Cuena for his support with the statistics.

Finally, the potential relevance of a molecular signature identified in terms of outcome prediction is unknown, and further research is needed to obtain this valuable biological information that may aid in classifying the patients.

Randomized controlled trial of screening for hepatocellular carcinoma. There is only one prospective trial globally validating the BCLC system In the report hepatlcarcinoma Grieco 35the median survival was In this way, in the last years there were improvements in the different prognostic scores.


Between January and Novemberconsecutive HCC patients were prospectively included in this study. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. The decision for therapy was made by the specialist claificacion and in special cases made by a multidisciplinary team consisting of hepatologists, oncologists, radiologists and surgeons.

Staging systems in hepatocellular carcinoma

Introduction Hepatocellular carcinoma HCC is the most common primary liver malignancy 1 and is the major cause of deaths in patients clasificqcion cirrhosis 2,3. Percutaneous treatments provide good results, but are unable to match the outcomes achieved with surgery Analysis of 5, cases from a medical center in southern Taiwan. Natural history of untreated nonsurgical hepatocellular carcinoma: It could also aid in the management of HCC patients on waiting list or in the election of the best possible treatment for hepatocwrcinoma patients.

In contrast, the BCLC system has recently been validated in American 26 and Italian 14 cohorts, and was shown to be of better predictive power for survival than other staging systems for HCC. The conventional TNM system, which only contains variables related to tumor stage, has been mostly tested in the surgical setting, and showed poor prognostic prediction in HCC patients undergoing either resection 39 or transplantation The process of carcinogenesis The molecular pathogenesis of HCC is complex 12 A patient was excluded from the analyses because AFP was not available at diagnosis.

Levy I, Sherman M.